Absci Q1 Revenue Misses Estimates by Over 85%, Reports $29.6M Net Loss
ABSI has more than doubled off its 52-week low of $2.24.
Summary
Absci Corp reported Q1 results, revealing a significant revenue miss and continued substantial net losses. The company posted revenue of $215 thousand, falling far short of the IBES estimate of $1.55 million, indicating a substantial operational shortfall. This revenue underperformance, coupled with a net loss of $29.599 million and operating income of -$30.846 million, suggests ongoing financial challenges. While the previous 10-K already indicated increased net losses and decreased revenue, this specific Q1 miss against analyst expectations is new and material information for traders. Investors will be watching for management's commentary on future revenue generation and cost control measures.
At the time of this announcement, ABSI was trading at $5.66 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $893.8M. The 52-week trading range was $2.24 to $6.24. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.